The Hepatitis Be Antibody (anti-HBe) Test is a qualitative blood test that detects antibodies to the hepatitis B e antigen and reports results as Reactive or Non-Reactive. A reactive result often indicates lower infectivity and a transition toward recovery or inactive disease, while a non-reactive result suggests no antibodies were detected. Doctors use this test to monitor hepatitis B infection stage, evaluate treatment response, and support long-term disease management.

The Hepatitis A Test is a qualitative test that checks for antibodies to the hepatitis A virus. Results are given as Reactive or Non-Reactive. While it does not identify the specific antibody type, the test is useful for showing if someone has been exposed to hepatitis A

The Hepatitis A Antibody Total Test is a qualitative test that detects antibodies to hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. It does not distinguish between IgM and IgG antibodies. A reactive result may indicate past infection or immunity from vaccination, while a non-reactive result suggests no prior exposure. Doctors use this test to assess immune status, guide vaccination decisions, and evaluate risk of hepatitis A infection.

The Hepatitis C Viral RNA Quantitative Test measures the amount of hepatitis C virus (HCV) RNA in blood to determine viral load. This test confirms active infection, evaluates disease severity, and monitors response to antiviral therapy. High viral load indicates significant viral replication, while lower or undetectable levels suggest effective treatment or controlled infection. Doctors use this test to guide therapy, track progress, and manage long-term liver health.

The Acute Hepatitis Panel with Reflex to Confirmation detects recent or acute infection by hepatitis A (IgM), B (surface antigen, core IgM), and C (antibody with reflex to RNA PCR) using immunoassay. Reflex confirmation ensures accurate diagnosis for hepatitis B surface antigen positives and reactive HCV antibodies. Use is indicated for symptomatic patients with jaundice, dark urine, fatigue, abdominal pain, or elevated liver enzymes.

The General Hepatitis Panel Test screens for multiple hepatitis infections in one order. It includes Hepatitis A Antibody Total, Hepatitis B Surface Antibody Qualitative, Hepatitis B Surface Antigen with Reflex to Confirmation, Hepatitis B Core Antibody Total, and Hepatitis C Antibody with Reflex to RNA PCR. Doctors use this panel to detect past exposure, confirm active or chronic infection, guide treatment, and support liver health monitoring.

The Hepatitis B Core IgM Antibody Test is a qualitative test that detects IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) and reports results as Reactive or Non-Reactive. A reactive result indicates a recent or acute hepatitis B infection, while a non-reactive result suggests no active infection. Doctors order this test to confirm acute hepatitis B in patients with symptoms such as jaundice, fatigue, fever, or abdominal pain and to guide treatment and monitoring.

The Hepatitis A & B Titer Test Panel is a comprehensive diagnostic tool designed to evaluate an individual's immunity status or infection presence for Hepatitis A and Hepatitis B viruses. This panel combines serological assays that measure specific antibodies and antigens associated with Hepatitis A and B, providing crucial insights for clinical diagnosis, vaccination verification, and the assessment of immune response post-vaccination or post-exposure.

The Hepatitis B Core Antibody Total Test is a qualitative blood test that detects antibodies to the hepatitis B core antigen (anti-HBc) and reports results as Reactive or Non-Reactive. A reactive result may indicate past or ongoing infection, while a non-reactive result suggests no exposure. This test does not distinguish between IgM and IgG antibodies. Doctors use it to evaluate hepatitis B exposure, confirm infection history, and assess overall immune response.

The Hepatitis C Antibody with HCV RNA Quantitative PCR test is a comprehensive diagnostic test used to detect and confirm the presence of the Hepatitis C virus (HCV) in the blood. It combines the initial screening for HCV antibodies with a quantitative polymerase chain reaction (PCR) test to measure the viral load.

The Hepatitis B Surface Antibody Qualitative Test detects anti-HBs antibodies to the hepatitis B surface antigen and reports results as Reactive or Non-Reactive. A reactive result indicates past exposure, either from hepatitis B infection or prior vaccination, while a non-reactive result suggests no detectable exposure. Doctors use this test to confirm hepatitis B exposure history, evaluate vaccine response, and guide further preventive or diagnostic decisions.

The Hepatitis B Surface Antibody Quantitative Test measures the exact level of anti-HBs antibodies in blood to determine past exposure and whether protective immunity has developed from infection or vaccination. A higher antibody level generally indicates adequate immune response, while a low level suggests limited or no protection. Doctors use this test to confirm vaccine effectiveness, assess immune status, and support hepatitis B screening or preventive care.

The Hepatitis C Viral RNA Genotype Lipa Test analyzes RNA to determine the genotype of the hepatitis C virus. Genotyping is essential because HCV strains vary in treatment response and prognosis. This test provides key insights into viral behavior, supports treatment planning, and aids in monitoring patients with chronic hepatitis C, helping guide decisions that impact long-term liver health outcomes.

 The Hepatitis B Titer Test Panel is a diagnostic panel that comprises three essential tests designed to assess immunity, infection status, and antibody levels for the Hepatitis B virus (HBV). The panel includes the following tests: Hepatitis B Core Antibody Total, Hepatitis B Surface Antibody Quantitative, and Hepatitis B Surface Antigen with Reflex Confirmation.

 The Hepatic Panel is a comprehensive set of blood tests designed to evaluate the function of the liver. This panel measures various enzymes, proteins, and substances in the blood that are either produced by the liver or released when liver cells are damaged. It provides crucial information about the liver's condition, aiding in the diagnosis, monitoring, and differentiation of liver disorders.

The Hepatitis B Core Antibody Total Test with Reflex to IgM detects antibodies (anti-HBc) to the hepatitis B core antigen. If the total antibody test is reactive, reflex testing determines if IgM antibodies are present, which indicates recent or acute infection. A reactive total with non-reactive IgM suggests past or chronic infection. Doctors use this test to confirm exposure, distinguish acute from prior infection, and support hepatitis B screening and diagnosis.

The Hepatitis A IgM Antibody Test is a qualitative blood test that detects IgM antibodies to the hepatitis A virus (HAV) and reports results as Reactive or Non-Reactive. A reactive result usually indicates a recent or current hepatitis A infection, while a non-reactive result means no active infection. Doctors use this test to confirm acute hepatitis A in patients with symptoms like jaundice, nausea, fatigue, or abdominal pain and to guide timely treatment and prevention.

The Hepatitis Be Antigen (HBeAg) Test is a qualitative blood test that detects the presence of hepatitis B e antigen and reports results as Reactive or Non-Reactive. A reactive result suggests active viral replication and high infectivity, while a non-reactive result indicates no HBeAg detected. Doctors use this test to evaluate hepatitis B disease stage, monitor treatment effectiveness, and assess risk of transmission, supporting long-term infection management.

The Hepatitis B Test (Hepatitis B Surface Antigen with Reflex to Confirmation) screens for hepatitis B surface antigen (HBsAg) in the blood to identify active infection. If the result is positive, a confirmation test is automatically performed to verify accuracy and support proper diagnosis.